-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Shijiazhuang Sihua Pharmaceutical: As Low-Temperature Snowfall Strikes, We Are Fully Committed to Safeguarding the “Lifeline” of Pharmaceutical Supply
Category:
发布时间：2025-12-13
【概要描述】
On December 12, Shijiazhuang experienced its first snowfall of the winter. The cold wave and heavy snowfall posed a severe challenge to transportation and placed higher demands on pharmaceutical logistics and delivery. In response to the inclement weather, Shijiazhuang No.4 Pharmaceutical promptly activated its emergency plan, coordinating production, logistics, and distribution resources to implement multiple measures aimed at keeping the “lifeline” of drug supply unimpeded and providing solid support for the peak winter demand for medications.
On December 12, Shijiazhuang experienced its first snowfall of the winter. The cold wave and heavy snowfall posed a severe challenge to transportation and placed even higher demands on pharmaceutical logistics and delivery. In response to the inclement weather, Shijiazhuang No.4 Pharmaceutical promptly activated its emergency plan, coordinating production, logistics, and distribution resources to implement multiple measures aimed at keeping the “lifeline” of drug supply unimpeded and providing solid support for the peak winter demand for medications.
Currently, we are in the peak influenza season, leading to a significant increase in clinical demand for medications. Adhering to its mission of ensuring supply, Shijiazhuang Sihua Pharmaceutical has implemented scientific production scheduling and capacity optimization. As a result, all production lines at its manufacturing facilities in the Shijiazhuang High-tech Industrial Development Zone and the Economic Development Zone—covering intravenous solutions, aqueous injections, and oral formulations—are operating at full capacity, with every effort devoted to producing key pharmaceutical products such as antiviral agents, antibacterial drugs, antipyretic analgesics, therapeutic formulations, and basic infusion solutions, thereby meeting the needs of markets across the country, particularly those selected through national and local centralized procurement programs.
To ensure the safe and timely delivery of pharmaceutical products, Shijiazhuang No. 4 Pharmaceutical leverages an information-based logistics management platform to conduct real-time dispatching of its distribution network. The logistics management team integrates real-time meteorological and road-condition data to promptly adjust shipping schedules and routes, thereby achieving dynamic optimization of transportation plans. In regions heavily affected by snowfall, such as North China and Northeast China, Shijiazhuang No. 4 Pharmaceutical proactively activates its highway transportation emergency response mechanism, deploying more than 200 dedicated support vehicles on key logistics routes and prioritizing the loading and dispatch of urgently needed medications. Meanwhile, employees in sales, warehousing, and logistics operate on a 24-hour “online” basis, continuously monitoring market demand and the status of pharmaceutical logistics to ensure prompt responses to any unexpected needs.
In the battle to ensure supply amid fierce winds and heavy snow, Shijiazhuang Sihua Pharmaceutical has maintained orderly production, smooth logistics, and reliable supply through coordinated and efficient internal management. From the production lines to the transportation network, employees have remained steadfast on the front lines, braving low temperatures and challenging travel conditions to ensure that every order is dispatched promptly and delivered on time.
Despite the harsh winds and snow, ensuring supply is non-negotiable. With a strong sense of responsibility and highly efficient execution, Shijiazhuang No.4 Pharmaceutical has erected a warm and reliable pharmaceutical supply defense line in the depths of winter, safeguarding the public’s medication safety through concrete actions—“producing high-quality medicines for the people”—thereby demonstrating the responsibility and commitment of a modern pharmaceutical enterprise.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091